Evidence map›Paper›PMID 26614961›Full record

ArticleThe lancet. HIV2015

Tackling latency as a barrier to an HIV cure: what next?

Christine Katlama, Dominique Costagliola, Brigitte Autran

Abstract readComment
PubMed Publisher
In one paragraph

Article in The lancet. HIV, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Fighting viruses with antibiotics: an overlooked path.International journal of antimicrobial agents · 2016
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Christine KatlamaDepartment of Infectious Diseases, Assistance publique-Hôpitaux de Paris, Pitié-Salpêtrière University Hospital, Paris, France; Institut Pierre-Louis d'Epidémiologie et de Santé Publique, Unité Mixte de Recherche en Santé 1136, Inserm, Paris, France; Université Pierre et Marie Curie Paris 06, Sorbonne Universités, F75013, Paris, France. Electronic address: christine.katlama@psl.aphp.fr.
Dominique CostagliolaInstitut Pierre-Louis d'Epidémiologie et de Santé Publique, Unité Mixte de Recherche en Santé 1136, Inserm, Paris, France; Université Pierre et Marie Curie Paris 06, Sorbonne Universités, F75013, Paris, France.
Brigitte AutranDepartment of Immunology, Assistance publique-Hôpitaux de Paris, Pitié-Salpêtrière University Hospital, Paris, France; Centre d'Immunologie et Maladies Infectieuses Paris, Inserm U1135, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HIV-1Virus LatencyAnti-HIV AgentsAntiretroviral Therapy, Highly ActiveCD4-Positive T-LymphocytesDisease ReservoirsHIVHIV AntibodiesHIV InfectionsHost-Pathogen InteractionsHumansVirus ActivationAnti-HIV AgentsHIV Antibodies

Identifiers

PMID26614961

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.